Aspen Aerogels, Inc. (NYSE:ASPN) Receives $5.94 Consensus Target Price from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned a consensus rating of “Hold” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $5.9375.

ASPN has been the subject of several research analyst reports. Wall Street Zen lowered shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. B. Riley Financial reissued a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Roth Capital restated a “buy” rating and issued a $7.75 price target on shares of Aspen Aerogels in a report on Friday, August 7th. Finally, Barclays lifted their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a research note on Tuesday, August 11th.

Aspen Aerogels Stock Down 1.1%

Shares of Aspen Aerogels stock opened at $5.08 on Friday. The stock’s 50-day moving average is $5.17 and its 200 day moving average is $4.80. Aspen Aerogels has a one year low of $2.30 and a one year high of $9.35. The firm has a market cap of $421.26 million, a price-to-earnings ratio of -3.32 and a beta of 2.97. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.The business had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Equities research analysts anticipate that Aspen Aerogels will post -0.69 EPS for the current year.

Institutional Trading of Aspen Aerogels

Large investors have recently made changes to their positions in the company. WINTON GROUP Ltd bought a new stake in Aspen Aerogels in the 2nd quarter valued at about $388,000. Baird Financial Group Inc. acquired a new position in Aspen Aerogels during the 2nd quarter worth approximately $2,189,000. Concurrent Investment Advisors LLC boosted its holdings in Aspen Aerogels by 6.7% in the second quarter. Concurrent Investment Advisors LLC now owns 32,050 shares of the construction company’s stock worth $203,000 after acquiring an additional 2,000 shares in the last quarter. Headlands Technologies LLC bought a new position in Aspen Aerogels in the second quarter worth approximately $174,000. Finally, Equitable Holdings Inc. acquired a new stake in Aspen Aerogels in the second quarter valued at approximately $88,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc is a technology company that develops, manufactures and sells advanced aerogel-based materials. Aerogels are highly porous materials designed to provide thermal insulation, fire protection and other performance benefits in applications where conventional insulation may be less effective or require more space.

The company serves the energy, industrial and automotive markets. Its products include thermal barriers for electric vehicle batteries, insulation materials for industrial and energy infrastructure, and specialty aerogel products used in applications involving heat management, fire mitigation and cryogenic or high-temperature environments.